Asset Details
Do you wish to reserve the book?
Attitudes and confidence toward deprescribing: a survey among Italian general practitioners
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Attitudes and confidence toward deprescribing: a survey among Italian general practitioners
Do you wish to request the book?
Attitudes and confidence toward deprescribing: a survey among Italian general practitioners
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Attitudes and confidence toward deprescribing: a survey among Italian general practitioners
2025
Overview
Background
General practitioners (GPs) should regularly review patients’ medications and, when they are potentially harmful or no longer necessary, implement deprescribing approach. We aimed to assess the perceptions and potential barriers to deprescribing among Italian GPs.
Methods
GPs were invited to participate in an observational cross-sectional study through an online survey containing 20 questions addressing attitudes towards deprescribing, including physicians’ perceptions, potential barriers, and how this process is addressed in daily clinical practice. The survey, accessible for responses from 4th May 2023 to 15th January 2024, was distributed through social media, networks, medical associations, and involving primary care departments of local health authorities.
Results
Over 8 months, 617 answers were collected. Less than 2% (
n
= 11) reported to not implement deprescribing interventions in daily practice, primarily due to perceived insufficient experience (
n
= 7) or lack of specific education (
n
= 6). Conversely, 23.1%(
n
= 142) of respondents reported frequently or very frequently implementing deprescribing. Among barriers, GPs reported difficulties in dealing with specialists (
n
= 438, 71.7%), distrust of patients in drug discontinuation (
n
= 326, 53.4%), poor availability of deprescribing guidelines (
n
= 231, 37.8%), and time constraints (
n
= 213, 34.9%). Guidelines and targeted training were mostly demanded (by 66.1% and 59.6%, respectively). Regarding specific drug classes, the proportion of GPs reporting to frequently implement deprescribing for proton pump inhibitors was 51.8% (
n
= 313), while percentage was lower for benzodiazepines (
n
= 166, 27.4%), bisphosphonates (
n
= 147, 24.3%), statins (
n
= 128, 21.2%), antihypertensives (
n
= 108, 17.9%), and antidepressants (
n
= 96, 15.9%).
Conclusion
The study shows that while GPs recognize the importance of deprescribing, however, they face significant barriers, including a lack in targeted education and specific guidelines to enhance their confidence and knowledge in implementing this process effectively in daily clinical practice.
Publisher
BioMed Central,BioMed Central Ltd,BMC
